Atorvastatin for thyroid eye disease
Treatments studied
Part of Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether atorvastatin, a cholesterol-lowering drug, can improve symptoms of thyroid eye disease (Graves' orbitopathy). It is for people with moderate-to-severe, active eye disease who have not recently used steroids or other treatments for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Graves' disease and are currently stable on thyroid medication.
- You have moderate-to-severe thyroid eye disease that has lasted no longer than 9 months.
- Your eye disease is active, meaning you have swelling, redness, or other signs of inflammation.
- You are between 18 and 75 years old.
- You have not used steroids, immunosuppressants, selenium, or statins in the last 3 months.
- You have no serious liver or muscle problems, and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether atorvastatin, a common cholesterol medicine, can reduce inflammation and improve eye symptoms in people with moderate-to-severe thyroid eye disease. It may help by calming the immune response that causes the eye problems.
This study tests whether tofacitinib, a new type of immune-modulating medication, can help people with moderate-to-severe thyroid eye disease (Graves' orbitopathy) whose eyes haven't improved with standard steroid treatments. The goal is to reduce eye swelling, bulging, and inflammation that affects daily life.
This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.
This trial tests whether targeted radiation to the eyes can help reduce the inflammation and symptoms of Graves' eye disease (also called thyroid eye disease). It is for people who have had eye symptoms for less than a year and whose eyes are still actively inflamed.
This study tests whether high-dose steroid pulses (given through a vein) can help people with moderate to severe Graves' eye disease that is still active. It is for people who have not yet been treated with steroids and whose eye problems began within the past year.
This trial tests two different ways of giving a steroid medicine called methylprednisolone through an IV to treat thyroid eye disease (also called Graves orbitopathy), which causes bulging and inflammation of the eyes. The goal is to see which schedule works better and has fewer side effects.
Hear when a new Graves Orbitopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.